Compliance and Oversight
As part of the settlement, Semler also agreed to adopt internal compliance measures under the oversight of the Department of Health and Human Services’ Office of Inspector General to prevent future misconduct.
The claims were first raised in a whistleblower lawsuit filed by two private parties, who will receive approximately $6.5 million from the recovery under the False Claims Act’s qui tam provisions.
No Immediate Comment
Representatives for Semler and Bard did not immediately respond to requests for comment Friday.
The settlement brings closure to a decade of alleged misrepresentations that prosecutors said improperly enriched the companies while depleting Medicare funds, reinforcing the DOJ’s aggressive stance on healthcare fraud and misuse of taxpayer dollars.
